Systematic use of the live attenuared mumps vaccines for the last four decades significantly reduced the incidence of disease and even resulted in its eradication in some parts of the world (1, 2) . However, reactogenicity due to a poor attenuation, the possibility of vaccine strain shedding and horizontal transmission represent some problems related with some mumps vaccine strains (3, 4, 5, 6, 7) . Although virus shedding following immunization with certain live attenuated mumps vaccine strain has been well documented, it is generally accepted that horizontal transmission of vaccine strains is a rare event, and to the best of our knowledge until now there have been only two reports in whom symptomatic disease developed as a consequence (6, 7) . Sawada et al. described in 1993 a horizontal transmission of the Urabe AM9 vaccine strain from a symptomatic vaccinee to her younger sister (6) , while recently a horizontal transmission of the Leningrad-3 mumps vaccine strain from healthy vaccinees to six previously vaccinated contacts resulting in symptomatic infection, has been described (7) . In both studies, parotitis developed as a unique consequence of horizontal transmission of mumps vaccine strains. Neither neurological, nor other extrasalivary abnormalities were seen among those patients, and none of them had to be hospitalized. All patients were in childhood age (6, 7) .
In Croatia the measles, mumps and rubella (MMR) vaccine containing Leningrad-Zagreb (L-Z) mumps vaccine strain has been a part of routine immunization programme for thirty-one years (9) . L-Z, originating from the Russian Leningrad-3 vaccine strain, has been successfully used in other parts of the former Yugoslavia, as well as in some of the developing countries (1, 10) . L-Z is a very immunogenic and efficacious strain, but even serious adverse reactions (e.g. aseptic meningitis), especially after primovaccination have been reported (9, 10, 11, 12) .
Although reactogenicity of L-Z strain, has been confirmed, and viremia and viral shedding among vaccinees is a probable event, not a single case of horizontal transmission of L-Z mumps vaccine strain has been reported to date in peer-review journals. (Table 1 ).
All three patients included in the study were adults. Both P2 and P3 had parotitis while P1 had parotitis, orchitis and AM. P2 and P3 were treated as outpatientswhile P1 was hospitalized for five days. No neurological sequelae were seen nor subjective complaints registered at the follow-up visit of P1 two months after the discharge.
In P1, urine and CSF samples for molecular analysis, and serum for serology were taken on the 2nd day of hospitalization. Throat swabs, urine samples and serum taken at the first visit were obtained from P2 and P3 (Table 1) µl of throat swab suspension, urine, CSF or vaccine sample and incubated 10 minutes at room temperature. After the addition of 96% ethanol, each sample was transferred into a QIAamp Mini spin column, centrifuged for 1 min at 8,000 rpm, and then washed with AW1 and AW2 buffers. Bound RNA was double eluted with 40 µl of AVE buffer. Prior to RNA extraction urine samples were centrifuged for 10 min at 1500 x g and only the supernatant was used.
A slightly modified nested SH/LZ RT-PCR assay, specific for mumps virus SH gene, was used to detect mumps RNA using the outer primer set SH1/SH2 for the first PCR amplification and the inner primer set LZ1/LZ2 for the second step, as described previously (14) . Briefly, the first PCR was carried out using OneStep RT-PCR Kit (Table 1 ). In P1 viral RNA was detected in CSF sample only. In P2, both the throat swab and urine sample were positive for viral RNA, while in P3 mumps virus RNA was successfully amplified from throat swab sample. Specific IgG and IgM antibody levels as well as neutralizing antibody titers of all patients are presented in Table 1 . All three patients were IgM-negative but had detectable levels of specific anti-mumps IgG antibodies. Neutralizing antibodies were detected only in serum sample of the P1, although the titer was low (1:8).
Horizontal transmission of mumps vaccine strains is a very rare event, and to the best of our knowledge until now only transmission among persons of childhood age has been described. All subjects in whom symptomatic disease developed as a consequence of horizontal transmission of vaccine strain had parotitis of benign course (7, 8) . No single case of symptomatic disease following horizontal transmission of mumps vaccine in an adult person has been reported to date, as well as no case of extrasalivary localization of infection. In contrast to previously reported cases, all three patients described in the present study were adult persons, one of whom developed two extrasalivary complications requiring hospitalization.
The possible source of infection in our patients was their own children who were recently primovaccinated with L-Z containing MMR vaccine. First symptoms of disease in patients appeared within 33 -44 days after the vaccination of their children.
Taking into account the duration of incubation period in natural mumps infection, as well as the timing of clinical presentation of previously described L-Z vaccinal complications, our data, although scarce, may suggest that viral shedding might have happened two to four weeks after the vaccination, which is consistent with the published data (8, 12, 16) .
In all our patients, the infection with L-Z was confirmed using RT-PCR targeting SH gene. Viral RNA was detected in throat swabs of P2 and P3 and in urine and CSF samples of P2 and P1, respectively. Interestingly, viral RNA was detected in only one out of three urine samples tested, although viruria in mumps infection is a frequent and long lasting event (16) . The presence of variable amounts of PCR inhibitors in the eluate could be the reason why the detection of mumps virus RNA in urine was less successful than in other clinical samples (17) .
All three patients in our study had detectable anti-mumps IgG antibodies. The most plausible explanation for the presence of specific anti-mumps antibodies in P1 and P2 might be the immunization with L-Z in early childhood, although all our patients were born in the period when epidemic parotitis was common in Croatian population, and previous asymptomatic infection with a wild strain can be another possibility (9) . Despite the presence of anti-mumps IgG antibodies, P1 had a very low titer (1:8), while P2 and P3 had undetectable neutralizing antibody levels. Our results thus support previously known facts that total IgG is not an appropriate correlate of protection to reinfection with mumps virus, and that ELISA is capable to detect a wide spectrum of anti-mumps antibodies, of which only a small proportion are able to neutralize the virus (7, 18). Low, or undetectable level of neutralizing anti-mumps antibodies provided the explanation why contact with a vaccine strain resulted in symptomatic infection.
In conclusion, the present report describes the first virologically confirmed cases of symptomatic mumps following horizontal transmission of mumps vaccine strain in adults. Our data suggest that the L-Z mumps vaccine strain can be transmitted horizontally, causing parotitis, as well as extrasalivary manifestations of the disease including meningitis, even among previously vaccinated subjects. Thus, a close monitoring of vaccinated children family members, especially mumps virus naive or those who had been vaccinated long time ago is highly advisable. 
